Vanderbilt Department of Psychiatry

Assistant Professor of Psychiatry
neil.woodward@vanderbilt.edu
http://www.mc.vanderbilt.edu/root/vumc.php?site=neilwoodward

Dr. Woodward joined the faculty in 2009.  He uses neuroimaging, neuropsychological testing, and genetics to investigate the neural basis of schizophrenia.  Neil is a NARSAD Young Investigator.

Education
B.Sc., University of Alberta, Canada
M.A., in Psychology, Vanderbilt University
Clinical Neuropsychology Internship, Edmonton Consortium Clinical Psychology Residency Program
Ph.D., in Clinical Psychology, Vanderbilt University

Postgraduate Training
Research Fellow, Psychiatric Neuroimaging Program, Vanderbilt University

Areas of Clinical Expertise
Schizophrenia, Bipolar Disorder

Research interests
Schizophrenia, Neuroimaging, Neuropsychology, Neuropharmacology, Genetics

Representative publications
1.  Woodward ND, Waldie B, Rogers B, Seres P, Tibbo P, Purdon SE.  (2009)  Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia.  Schizophrenia Research, 109(1-3): 182-190.

2. Kessler RM, Woodward ND, Riccardi P, Li R, Ansari MS, Anderson S, Dawant B, Zald DH, Meltzer HY.  (2009)  Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenia subjects.  Biological Psychiatry, 65(12): 1024-1031

3. Woodward ND, Zald DH, Li R, Ding Z, Riccardi P, Ansari MS, Dawant B, Anderson S, Baldwin R, Kessler RM.  (2009)  Cerebral morphology and dopamine D2/D3 receptor distribution in humans: A combined [18F]fallypride and voxel-based morphometry study.  Neuroimage, 46(1): 31-38. 

4. Woodward ND, Jayathilake K, Meltzer HY.  (2007)  COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.  Schizophrenia Research, 90(1-3): 86-96.

5.  Woodward ND, Purdon SE, Meltzer HY, Zald DH.  (2005) A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.  International Journal of Neuropsychopharmacology, 8(3): 457-472.